News: Norma Diagnostika Indonesia at PAMKI 2025 – Strengthening TB Case Finding with Truenat

Semarang, August 21–23, 2025 — PT Norma Diagnostika Indonesia proudly took part in the PIT/KONAS PAMKI 2025—the Annual Scientific Meeting and National Congress of the Indonesian Clinical Microbiology Specialist Association (PAMKI), held at PO Hotel Semarang. Carrying the theme “Integrating Clinical Microbiology and Genomics Diagnostics in National Health Systems”, the event brought together leading experts to address the challenges of infectious disease control in Indonesia.

At this prestigious forum, Norma Diagnostika Indonesia delivered a presentation on Active TB Case Finding, highlighting the importance of early detection and rapid diagnosis in supporting Indonesia’s TB elimination agenda.

As part of our commitment to innovation, we introduced the TCM Molbio (Truelab/Truenat platform) as a One-Step Solution for both screening and confirmatory testing of TB cases. With its portability, accuracy, and rapid turnaround time, TCM Molbio provides healthcare facilities with an integrated approach to streamline TB detection and diagnosis—empowering clinicians to take immediate and informed action.

Through this initiative, PT Norma Diagnostika Indonesia continues to strengthen its role as a trusted partner in advancing diagnostic excellence and supporting national health priorities.